HBX-41108 is a potent inhibitor of ubiquitin-specific protease (USP) 7 activity (IC₅₀ = 424 nM). Also inhibits USP7-mediated p53 deu biquitination (IC₅₀ = 0.8 μM). HBX-41108 treatment stabilizes p53, activates the transcription of a p53 target gene w

Item Number: BIOV9608-25

Unit of Measure: 25 MG

978.00 CHF 978.0 CHF 978.00 CHF

978.00 CHF

This combination does not exist.

ADD TO CART

Current delivery time on request

Manufacturer: BIOVISION

Manufacturer Number: 9608-25

Storage Temperature: Freezer (-20)

HBX-41108 is a potent inhibitor of ubiquitin-specific protease (USP) 7 activity (IC₅₀ = 424 nM). Also inhibits USP7-mediated p53 deu biquitination (IC₅₀ = 0.8 μM). HBX-41108 treatment stabilizes p53, activates the transcription of a p53 target gene w

HBX-41108 is a potent inhibitor of ubiquitin-specific protease (USP) 7 activity (IC₅₀ = 424 nM). Also inhibits USP7-mediated p53 deu biquitination (IC₅₀ = 0.8 μM). HBX-41108 treatment stabilizes p53, activates the transcription of a p53 target gene w

978.00 CHF 978.0 CHF 978.00 CHF

978.00 CHF

Not Available For Sale